Clincosm LogoSign in Get a demo

ovarian serous cystadenocarcinoma

Showing 1 - 23 of 23
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MSI-H Colorectal Cancer, Melanoma, Anal Carcinoma Trial in Spain (Spartalizumab)

Active, not recruiting
  • MSI-H Colorectal Cancer
  • +30 more
  • Badalona, Barcelona, Spain
  • +9 more
Oct 24, 2022

Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Tumor, Fallopian Tube Mucinous Tumor Trial in Rochester

Active, not recruiting
  • Fallopian Tube Clear Cell Adenocarcinoma
  • +22 more
  • Laboratory Biomarker Analysis
  • Multi-epitope Folate Receptor Alpha-loaded Dendritic Cell Vaccine
  • Rochester, Minnesota
    Mayo Clinic
Oct 7, 2022

Solid Tumor, Adult, Pancreatic Ductal; Adenocarcinoma, Ovarian Serous Adenocarcinoma Trial in United States (ZB131)

Recruiting
  • Solid Tumor, Adult
  • +4 more
  • Phoenix, Arizona
  • +8 more
Aug 31, 2022

Ovarian Brenner Tumor, Ovarian Carcinosarcoma, Ovarian Clear Cell Cystadenocarcinoma Trial in Canada, Singapore, United States

Active, not recruiting
  • Ovarian Brenner Tumor
  • +11 more
  • Duarte, California
  • +15 more
Aug 11, 2022

Brenner Tumor, Malignant Ascites, Malignant Pleural Effusion Trial in United States (metformin HCl, , Chemotherapy)

Suspended
  • Brenner Tumor
  • +27 more
  • metformin hydrochloride
  • +2 more
  • Birmingham, Alabama
  • +9 more
May 16, 2022

Ovarian Endometrioid Adenocarcinoma, Ovarian Seromucinous Carcinoma, Ovarian Serous Cystadenocarcinoma Trial in Jacksonville,

Completed
Has Results
  • Ovarian Endometrioid Adenocarcinoma
  • +8 more
  • Jacksonville, Florida
  • +1 more
Sep 28, 2020

Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma

Completed
  • Fallopian Tube Clear Cell Adenocarcinoma
  • +19 more
  • Hartford, Connecticut
  • +13 more
Aug 8, 2019

Brenner Tumor, Fallopian Tube Cancer, Ovarian Carcinosarcoma Trial in United States (carboplatin, paclitaxel, docetaxel)

Completed
  • Brenner Tumor
  • +12 more
  • Orange, California
  • +15 more
Jul 19, 2019

Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma Trial in Japan, United States (procedure, drug,

Completed
  • Brenner Tumor
  • +11 more
  • adjuvant therapy
  • +3 more
  • Orange, California
  • +18 more
Jul 19, 2019

Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Seromucinous Carcinoma Trial in United

Completed
  • Ovarian Clear Cell Cystadenocarcinoma
  • +7 more
  • Bevacizumab
  • +4 more
  • Aurora, Colorado
  • +12 more
Jul 19, 2019

Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma Trial in Seattle (biological,

Completed
  • Fallopian Tube Cancer
  • +10 more
  • denileukin diftitox
  • +4 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
May 13, 2019

Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Seromucinous Carcinoma Trial in United

Completed
  • Ovarian Clear Cell Cystadenocarcinoma
  • +7 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Birmingham, Alabama
  • +6 more
Mar 8, 2019

Ovarian Papillary Serous Carcinoma, Ovarian Serous Cystadenocarcinoma, Recurrent Fallopian Tube Cancer Trial in Philadelphia

Withdrawn
  • Ovarian Papillary Serous Carcinoma
  • +5 more
  • metformin hydrochloride
  • +3 more
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Feb 18, 2019

Nausea and Vomiting, Ovarian Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma Trial in Hinsdale, Providence (procedure,

Terminated
Has Results
  • Nausea and Vomiting
  • +26 more
  • Adjuvant Therapy
  • +7 more
  • Hinsdale, Illinois
  • +1 more
Apr 24, 2018

Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma Trial in Seattle (biological, drug, other)

Completed
Has Results
  • Brenner Tumor
  • +11 more
  • sargramostim
  • +3 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Jul 24, 2017

Malignant Ovarian Mixed Epithelial Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma Trial in

Terminated
  • Malignant Ovarian Mixed Epithelial Tumor
  • +7 more
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group
Aug 8, 2017

Collecting Tumor Samples From Patients With Gynecological Tumors

Completed
  • Borderline Ovarian Clear Cell Tumor
  • +85 more
  • Laboratory Biomarker Analysis
  • Fayetteville, Arkansas
  • +186 more
Oct 26, 2016

Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma Trial in Bronx (paclitaxel, carboplatin, erlotinib)

Completed
Has Results
  • Brenner Tumor
  • +8 more
  • Bronx, New York
    Montefiore Medical Center
Oct 29, 2015

Patients With Advanced Ovarian Epithelial Cancer

Withdrawn
  • Ovarian Serous Cystadenocarcinoma
  • +5 more
  • Comparative Genomic Hybridization
  • +2 more
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group
May 29, 2015

Fallopian Tube Carcinoma, Malignant Ovarian Mixed Epithelial Tumor, Ovarian Brenner Tumor Trial in Philadelphia (Carboplatin,

Completed
  • Fallopian Tube Carcinoma
  • +10 more
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group
May 7, 2015

Chemotherapeutic Agent Toxicity, Endometrial Adenocarcinoma, Fallopian Tube Carcinoma Trial in United States (Paclitaxel,

Completed
  • Chemotherapeutic Agent Toxicity
  • +14 more
  • Chicago, Illinois
  • +6 more
Dec 29, 2014

Fatigue, Malignant Ovarian Mixed Epithelial Tumor, Neuropathy Trial (Acetyl-L-Carnitine Hydrochloride, Placebo, Questionnaire

Withdrawn
  • Fatigue
  • +12 more
  • Acetyl-L-Carnitine Hydrochloride
  • +3 more
  • (no location specified)
Dec 29, 2014

Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma Trial in Phoenix (paclitaxel,

Completed
  • Brenner Tumor
  • +8 more
  • Phoenix, Arizona
    Gynecologic Oncology Group of Arizona
Jan 23, 2013